Latest ASX Announcements

ASX Announcement – WA Broker Meets Biotech presentation

Dimerix CEO Kathy Harrison is pleased to be speaking alongside a great collection of other biotech companies at the Western Australian AusBiotech Broker Meets Biotech event today.

Date: Wednesday 13 September 2017
Time: 1:00pm arrival for a 1:30pm start

Venue: Parmelia Hilton Perth
14 Mill Street
Perth, WA

Details and registration for the event are available

By | 2017-09-13T09:15:19+00:00 September 13th, 2017|Latest ASX Announcements|

Dimerix announces DMX-200 tablet manufacture and human pharmacokinetic study timeline

Dimerix Limited (ASX: DXB), is pleased to announce that manufacturing has been scheduled for later this month to produce the extended release tablet of propagermanium which will be used in the Company’s DMX-200 human pharmacokinetic study and Phase 2b trial in Chronic Kidney Disease.

Read the full release here.

By | 2017-09-05T07:49:25+00:00 September 5th, 2017|Latest ASX Announcements|

Video: NDF Research interview on Phase 2a results

In the interview, Kathy Harrison and Associate Professor David Packham, a Principal Investigator in the DMX-200 Phase 2a study and Director of Melbourne Renal Research Group, discusses Dimerix’s Phase 2a trial result of DMX-200 with Stuart Roberts, Senior Analyst with NDF Research.

The full interview is available here.